Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
about
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signalingPTPN14 is required for the density-dependent control of YAP1Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth controlMerlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleusAjuba LIM proteins are negative regulators of the Hippo signaling pathwayWW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZMolecular mechanism of WW-domain binding protein-2 coactivation function in estrogen receptor signalingβ-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesisTAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathwayPTPN14 interacts with and negatively regulates the oncogenic function of YAPNuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathwaysAngiomotin-like proteins associate with and negatively regulate YAP1Angiomotin is a novel Hippo pathway component that inhibits YAP oncoproteinErk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferationTEAD mediates YAP-dependent gene induction and growth controlThe hippo signaling pathway in development and cancerStructures of YAP protein domains reveal promising targets for development of new cancer drugsα-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1Structural and functional analysis of the YAP-binding domain of human TEAD2RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor proteinThe neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAPExpression of Yes-associated protein in common solid tumorsFunctional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesisInduced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery behind ReprogrammingYAP-Mediated Mechanotransduction in Skeletal MuscleEmerging role of Hippo pathway in gastric and other gastrointestinal cancersEvasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.Reprogramming cells with synthetic proteinsThe two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatmentStructural insights into the YAP and TEAD complexStructural basis of YAP recognition by TEAD4 in the Hippo pathwayTargeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer TherapyEmerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancerOpposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAPGenetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survivalInteraction with WDR5 promotes target gene recognition and tumorigenesis by MYCHippo Pathway in Organ Size Control, Tissue Homeostasis, and CancerRedundant roles of Tead1 and Tead2 in notochord development and the regulation of cell proliferation and survivalThe Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
P2860
Q24293710-A8895E24-A7EC-42A6-86F0-07DFB09D3C78Q24294906-7B3C8A69-1579-4914-BAFD-03AE72AE7ED3Q24297998-8B31DF37-4209-4F6C-9ED3-7F4E34265E5FQ24299106-7C879EA2-C210-48C7-AE3E-139AA45ED110Q24300770-E0CDFECF-9988-4351-A2B8-503A81D56827Q24304074-3510080B-EA1A-4CFA-973E-6C0DD6924C4BQ24304338-ACD3C394-2DEF-4954-9460-E87A9F406702Q24305590-CC03205A-166C-42BD-B948-E07827FD0793Q24306274-68CF9566-A8CE-40D2-995C-17532A6760A4Q24307937-D9C1B0F2-9738-4B39-A368-910E3488173AQ24316475-F67C941A-4C41-4A22-A5EE-EDE548944AF6Q24317164-281641F5-CA8C-476D-A219-21F04D09504BQ24321532-E2F8D855-DFEB-42B3-86D7-8F01EF5F4795Q24323326-59E7C0BE-997C-4C1A-95C0-0105F2235118Q24323390-57DCC6A1-C8F4-4FC9-A5A0-598A35965B22Q24336045-4ED93D53-4819-4EB2-831F-A6D47606DCA7Q24603986-92A7D965-33A9-4D1B-A3AA-88E01CE2094AQ24612471-25899683-2C5A-4975-A9BE-58543DA6379CQ24613385-15E0FB6C-B78E-4BCD-A770-6CF26D20398EQ24623055-39AF0914-F41C-4889-BF56-B99A617A9963Q24648062-D925CC02-E326-47BE-9552-330D4954EF2AQ24650089-9A31D4D1-A0E5-4BA0-AAD1-EBB2ED27D6A2Q24657592-9DB8B60F-754C-4682-9A32-2B70F050473CQ24681265-4B2BF7B3-9425-4682-9F46-C51F96DC554DQ26765848-F8C56212-ADF4-4B78-988E-0A854243C097Q26766774-22D4D8A0-6012-4EC1-9F31-079DFF226B24Q26774473-A4471C36-171F-4C21-8D03-558792B2BCEBQ26827810-3641C4D3-6410-432F-905A-83E2303FCDF1Q26853155-A6654D92-2AC9-45CC-95A9-A56FC22406ECQ27025661-10AEC9FA-F06D-4CB8-828E-D8A88538C0ECQ27659386-66EEFE77-C6CB-4562-90D5-B7F2CFEF8CA6Q27659390-A74A08AE-E514-44F7-AA5E-394C8BE2BA18Q28078129-9B36405C-09BE-49D0-B4A6-FB78DBE0A5D7Q28086905-75D423EB-7559-4B48-B0B2-CB4011EA0DACQ28241192-208988E1-355A-4F6D-8F34-5A086DC6B22EQ28256045-F76970DE-3216-4671-9663-378F87AA7C23Q28259591-B6BAAB17-A658-4BAA-9CC5-7111DD865983Q28269498-608DC715-A7E0-49E3-93CC-63B01912B926Q28272202-BBFA8653-1A1A-4683-A743-293AF1C39983Q28281214-98E720AE-9A19-495E-9573-3A238048AB11
P2860
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
@ast
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
@en
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
@nl
type
label
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
@ast
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
@en
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
@nl
prefLabel
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
@ast
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
@en
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
@nl
P2093
P2860
P3181
P356
P1476
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
@en
P2093
Chu-Xia Deng
Daniel A Haber
Dennis C Sgroi
Gromoslaw A Smolen
Jianmin Zhang
Joan S Brugge
P2860
P304
P3181
P356
10.1073/PNAS.0605579103
P407
P577
2006-08-15T00:00:00Z